This is the first study to show SHC1 is upregulated in brain and CNS cancers, head and neck cancers, kidney cancer, liver cancer, lung cancer, melanoma, and prostate melanoma using the Oncomine database. This evidence concerns the gene SHC1 and head and neck cancer.